SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 8,017,150 Expiration: Feb 13, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug …
Drug Patent Expirations for the Week of February 12, 2023 Read Post »
Annual Drug Patent Expirations for SPRAVATO Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Janssen Pharms drug SPRAVATO appeared first on DrugP…
Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent for Tolmar drug JATENZO appeared first on DrugPatentWa…
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug p…
Which pharmaceutical companies have the most drug patents in Luxembourg? Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Indivior Inc drug SUBOXONE appeared firs…
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug patents in Euro…
Which pharmaceutical drugs have the most drug patents in European Patent Office? Read Post »
Annual Drug Patent Expirations for LEXAPRO Lexapro is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Allergan drug LEXAPRO appeared first…
Annual Drug Patent Expirations for LEXAPRO Lexapro is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Allergan drug LEXAPRO appeared first…
Annual Drug Patent Expirations for SYMPAZAN Sympazan is a drug marketed by Otter Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Otter Pharms drug SYMPAZAN appeared first on DrugPat…
Annual Drug Patent Expirations for SYMPAZAN Sympazan is a drug marketed by Otter Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Otter Pharms drug SYMPAZAN appeared first on DrugPat…
Get new actionable insights and updates from BiotechBlog
